Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Huchappa, Jayappa"'
Autor:
Huchappa Jayappa, Ronald D. Schultz, Bliss Thiel, Tamara Davis, Nallakannu Lakshmanan, Jamie Henningson, Muralidhar S. Deshpande, Patricia Sharp, Terri Lee Wasmoen, Laurie J. Larson
Publikováno v:
Clinical and Vaccine Immunology
Since first emerging in the North American canine population in 2004, canine influenza virus (CIV) subtype H3N8 has shown horizontal transmission among dogs, with a high level of adaptation to this species. The severity of disease is variable, and co
Autor:
Robbie L. McLeod, Deen Tulshian, Leonard E. Parra, Ahmad Fawzi, Xiomara Fernandez, Donald C. Bolser, Jennifer C. Zimmer, Craig Lehr, Jason Erskine, Huchappa Jayappa, April Smith-Torhan, Christine H. Erickson, Hongtao Zhang, Ginny D. Ho, John A. Hey
Publikováno v:
Pharmacology. 84:153-161
Background: Previous studies have demonstrated that nociceptin/orphanin FQ (N/OFQ), the endogenous peptide ligand for the G-protein-coupled NOP receptor, inhibits cough in experimental models. SCH 225288 is a nonpeptide, orally active NOP agonist tha
Autor:
Laurie J. Larson, Muralidhar S Deshp, Patricia Sharp, Huchappa Jayappa, Tamara Davis, Nallakannu Lakshmanan, Jamie Henningson, Ronald D. Schultz, Terri Lee Wasmoen, Marie E Pinkerton, Bliss Thiel
Publikováno v:
Journal of Veterinary Science & Medical Diagnosis.
Efficacy of Canine Influenza Virus (H3N8) Vaccine to Reduce Pulmonary Lesions after Co-challenge with Canine Influenza Virus and Streptococcus equi subsp. zooepidemicus To examine the effectiveness of canine influenza vaccination to reduce pulmonary
Autor:
Muralidhar S, Deshpande, Faris F, Jirjis, Anna L, Tubbs, Huchappa, Jayappa, Diane, Sweeney, Stephen J, Spencer, Nallakannu, Lakshmanan, Terri L, Wasmoen
Publikováno v:
Veterinary therapeutics : research in applied veterinary medicine. 10(3)
Canine influenza virus (CIV) subtype H3N8 is an emerging pathogen with sustained horizontal transmission in the dog population in the United States. This study evaluated the efficacy of an inactivated CIV vaccine in 6- to 8-week-old beagle pups chall
Autor:
Terri Lee Wasmoen, Huchappa Jayappa, Faris F Jirjis, Anna L. Tubbs, Nallakannu Lakshmanan, Muralidhar S. Deshpande
Publikováno v:
Veterinary microbiology. 144(3-4)
Canine influenza virus (CIV) is an emerging pathogen that causes acute respiratory disease in dogs. As with any communicable disease, dog-to-dog transmission of CIV occurs when infected dogs come in contact with other susceptible dogs. We demonstrate
Publikováno v:
Veterinary therapeutics : research in applied veterinary medicine. 10(1-2)
Canine influenza virus (CIV) subtype H3N8 has emerged as a new pathogen with sustained transmission in the dog population in the United States. In this study, we report the experimental induction of respiratory disease in dogs using three CIV field i
Autor:
Craig, Lehar, Huchappa, Jayappa, Jason, Erskine, Alicia, Brown, Diane, Sweeney, Terri, Wassmoen
Publikováno v:
Veterinary therapeutics : research in applied veterinary medicine. 9(4)
Three groups of healthy dogs with low antibody titers to Bordetella bronchiseptica (Bb), canine parainfluenza virus (CPI), and canine adenovirus type 2 (CAV-2) were used in this study. One group was vaccinated with a single dose of monovalent attenua
Publikováno v:
Veterinary therapeutics : research in applied veterinary medicine. 9(4)
Enterotoxigenic Escherichia coli is one of the primary etiologic agents for diarrhea in neonatal calves. Immunization of dams can provide passive protection in neonatal calves; antibodies transferred through colostrum block colonization of bacteria,
Autor:
Randy, Davis, Huchappa, Jayappa, Omar Y, Abdelmagid, Rob, Armstrong, Diane, Sweeney, Craig, Lehr
Publikováno v:
Veterinary therapeutics : research in applied veterinary medicine. 8(1)
Healthy dogs with low antibody titer to Bordetella bronchiseptica were vaccinated intranasally with an avirulent live vaccine, subcutaneously with an antigen extract vaccine, or subcutaneously and intranasally with a placebo. Intranasally vaccinated